Human natural killer cells:: a unique innate immunoregulatory role for the CD56bright subset

被引:1006
作者
Cooper, MA
Fehniger, TA
Turner, SC
Chen, KS
Ghaheri, BA
Ghayur, T
Carson, WE
Caligiuri, MA
机构
[1] Ohio State Univ, Dept Internal Med, Div Hematol Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[4] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[5] BASF Biores Corp, Worcester, MA USA
关键词
D O I
10.1182/blood.V97.10.3146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During the innate immune response to infection, monocyte-derived cytokines (monokines), stimulate natural killer (NK) cells to produce immunoregulatory cytokines that are important to the host's early defense. Human NK cell subsets can be distinguished by CD56 surface density expression (ie, CD56 blight and CD56(dim)). In this report, it is shown that CD56(bright) NK cells produce significantly greater levels of interferon-gamma, tumor necrosis factor-beta, granulocyte macrophage-colony-stimulating factor, IL-10, and IL-13 protein in response to monokine stimulation than do CD56(dim) NK cells, which produce negligible amounts of these cytokines. Further, qualitative differences in CD56(bright) NK-derived cytokines are shown to be dependent on the specific monokines present. For example, the monokine IL-15 appears to be required for type 2 cytokine production by CD56(bright) NK cells. It is proposed that human CD56(bright) NK cells have a unique functional role in the innate immune response as the primary source of NK cell-derived immunoregulatory cytokines, regulated in part by differential monokine production. (Blood. 2001;97:3146-3151) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:3146 / 3151
页数:6
相关论文
共 36 条
  • [1] Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin
    André, P
    Spertini, O
    Guia, S
    Rihet, P
    Dignat-George, F
    Brailly, H
    Sampol, J
    Anderson, PJ
    Vivier, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3400 - 3405
  • [2] COOPERATION OF NATURAL-KILLER-CELL STIMULATORY FACTOR INTERLEUKIN-12 WITH OTHER STIMULI IN THE INDUCTION OF CYTOKINES AND CYTOTOXIC CELL-ASSOCIATED MOLECULES IN HUMAN T-CELLS AND NK-CELLS
    ASTEAMEZAGA, M
    DANDREA, A
    KUBIN, M
    TRINCHIERI, G
    [J]. CELLULAR IMMUNOLOGY, 1994, 156 (02) : 480 - 492
  • [3] THE ROLE OF NATURAL-KILLER-CELLS IN INNATE RESISTANCE TO INFECTION
    BANCROFT, GJ
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (04) : 503 - 510
  • [4] DIFFERENTIAL RESPONSES TO INTERLEUKIN-2 DEFINE FUNCTIONALLY DISTINCT SUBSETS OF HUMAN NATURAL-KILLER-CELLS
    BAUME, DM
    ROBERTSON, MJ
    LEVINE, H
    MANLEY, TJ
    SCHOW, PW
    RITZ, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (01) : 1 - 6
  • [5] Natural killer cells in antiviral defense: Function and regulation by innate cytokines
    Biron, CA
    Nguyen, KB
    Pien, GC
    Cousens, LP
    Salazar-Mather, TP
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 189 - 220
  • [6] FUNCTIONAL CONSEQUENCES OF INTERLEUKIN-2 RECEPTOR EXPRESSION ON RESTING HUMAN-LYMPHOCYTES - IDENTIFICATION OF A NOVEL NATURAL-KILLER-CELL SUBSET WITH HIGH-AFFINITY RECEPTORS
    CALIGIURI, MA
    ZMUIDZINAS, A
    MANLEY, TJ
    LEVINE, H
    SMITH, KA
    RITZ, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) : 1509 - 1526
  • [7] CALLGIURI MA, 1993, J CLIN INVEST, V91, P123
  • [8] CD56(bright) natural killer cell subsets: Characterization of distinct functional responses to interleukin-2 and the c-kit ligand
    Carson, WE
    Fehniger, TA
    Caligiuri, MA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) : 354 - 360
  • [9] INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR
    CARSON, WE
    GIRI, JG
    LINDEMANN, MJ
    LINETT, ML
    AHDIEH, M
    PAXTON, R
    ANDERSON, D
    EISENMANN, J
    GRABSTEIN, K
    CALIGIURI, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1395 - 1403
  • [10] Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro
    Carson, WE
    Ross, ME
    Baiocchi, RA
    Marien, MJ
    Boiani, N
    Grabstein, K
    Caligiuri, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) : 2578 - 2582